| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373309A2 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373291A2 Antisense modulation of recql4 expression |
| 01/02/2004 | EP1373246A2 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1372922A1 Inventory management system |
| 01/02/2004 | EP1372828A2 Biochips including ion transport detecting structures and methods of use |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP1372736A2 Anti-neovasculature preparations for cancer |
| 01/02/2004 | EP1372721A2 Method to screen peptide display libraries using minicell display |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372714A2 Method for inducing an immune response to polysaccharide bacterial antigens and to protein structures of virus capsids |
| 01/02/2004 | EP1372697A2 Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c, and corresponding screening method |
| 01/02/2004 | EP1372690A2 93870, a human g-protein coupled receptor and uses therefor |
| 01/02/2004 | EP1372689A2 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 01/02/2004 | EP1372418A2 Non-oligomerizing tandem fluorescent proteins |
| 01/02/2004 | EP0934428B1 Microbiological assessment method and device utilizing oxygen gradient sensing |
| 01/02/2004 | EP0931166B1 Methods for determining sequence information in polynucleotides using mass spectrometry |
| 01/02/2004 | EP0858597B1 Transistor-based apparatus and method for molecular detection |
| 01/02/2004 | EP0663008B1 Improvements in or relating to immune response modification |
| 01/01/2004 | US20040003422 An expression cassette containing the proopiomelanocortin (POMC) enhancer, and a nucleic acid sequence encoding POMC contains at least one exon, wherein a polylinker having an unique site for restriction enzyme is inserted into the exon; gene regulates weight and fat mass |
| 01/01/2004 | US20040003419 Novel taste receptors in Drosophila |
| 01/01/2004 | US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer |
| 01/01/2004 | US20040002819 Computer-aided probability base calling for arrays of nucleic acid probes on chips |
| 01/01/2004 | US20040002595 Nucleic acid labeling compounds |
| 01/01/2004 | US20040002592 A nucleic acid molecule, a kit which comprises the nucleic acid molecule, and a method for detecting fungi in clinical material and for determining the sequence of ribosomal fungal genes, and kits for carrying out these methods |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002470 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease |
| 01/01/2004 | US20040002460 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 01/01/2004 | US20040002441 Antitumor agents; anticancer agents; bactericides; polymerase chain reactions |
| 01/01/2004 | US20040002154 Methods for preparing libraries of unique tags and related screening methods |
| 01/01/2004 | US20040002149 Control of the ratio of LAP to LIP |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002132 Bacterial plaque evidencing composition based on natural colorants |
| 01/01/2004 | US20040002131 Housing comprising a support and top member; wells configured to receive sample; use for understanding disease processes and developing and evaluating drugs |
| 01/01/2004 | US20040002130 Detecting Pseudomonas quinolone signal production in bacterial cells by culturing, preparing extract of supernatant and exposing it to ultraviolet light and determining emission of blue fluorescence; methyl anthranilate; use in treating |
| 01/01/2004 | US20040002129 Incubating the enzyme and labeled arginine which is converted into citrulline; separating and capturing using a filter plate membrane; high-throughput screening for modulators |
| 01/01/2004 | US20040002128 Green fluorescent protein; activation by caspase or protease; determining change in the degree of fluorescence resonance energy transfer |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 01/01/2004 | US20040002122 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 01/01/2004 | US20040002114 Nucleic acids encoding a G-protein coupled receptor involved in islet cell signaling |
| 01/01/2004 | US20040002110 Improved analyte-specific diffraction based diagnostic sensor to indicate the presence of the analyte in a medium |
| 01/01/2004 | US20040002109 Process for identifying modulators of G-protein-coupled receptors |
| 01/01/2004 | US20040002108 Predicting the significance of single nucleotide polymorphisms (SNPs) using ensemble-based structural energetics |
| 01/01/2004 | US20040002104 Constant length signatures for parallel sequencing of polynucleotides |
| 01/01/2004 | US20040002103 Synthetic ligation reassembly in directed evolution |
| 01/01/2004 | US20040002101 Method and kit for discovering nucleic acids that encode desired functions |
| 01/01/2004 | US20040002100 Comprises assaying a suppressing effect of a test substance on an expression of a splicing variant transcribed from presenilin-2 gene |
| 01/01/2004 | US20040002098 Observing hybridization with fluorescence during and/or immediately after PCR and using this information for product identification, sequence alteration detection, and quantification; fluorescence resonance energy transfer (fret) |
| 01/01/2004 | US20040002097 Genetic suppressor elements that confer upon a cell resistance to chemotherapeutic drug, cloned human kinesin heavy chain gene involved in resistance to DNA damaging agents |
| 01/01/2004 | US20040002095 Universal signal amplification tail |
| 01/01/2004 | US20040002094 Method to monitor the changes in comprehensive cellular gene expression levels at single length resolution by using a high-density microarray prepared with a comprehensive collection of ORFs (open reading frame) of a genome |
| 01/01/2004 | US20040002093 Nucleic acid detection method |
| 01/01/2004 | US20040002091 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040002090 Detecting in a population of organisms of a species genome-wide sequence variations associated with a phenotype in a hypothesis-free manner |
| 01/01/2004 | US20040002087 Nucleic acid for detecting endocrine disrupting property of chemical substance, nucleic acid detecting probe and nucleic acid detecting primer containing the nucleic acid, probe-immobilized chip comprising the nucleic acid detecting probe, peptide derived from the nucleic acid and antibody recognizing the peptide, probe-immobilized chip comprising the antibody, and method of detecting endocrine disrupting property of chemical substance using them |
| 01/01/2004 | US20040002085 Apparatus, systems and method for assaying biological materials using an annular format |
| 01/01/2004 | US20040002083 Predicting single-stranded regions in the secondary structure of a nucleic acid molecule in accordance with a probability distribution of structures based on recursively generated partition functions for the identification of accessible sites |
| 01/01/2004 | US20040002082 Methods for identifying cancer risk |
| 01/01/2004 | US20040002080 Primers for use in detecting beta-lactamases |
| 01/01/2004 | US20040002079 Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness |
| 01/01/2004 | US20040002078 Arrays |
| 01/01/2004 | US20040002076 Sequencing and performing polymerase reactions using an improved generation of nucleic acid polymerases; comprises fusion of a sequence-non-specific nucleic-acid-binding domain to the enzyme to enhances the processivity of the polymerase |
| 01/01/2004 | US20040002074 Compositions and methods for the determination of the presence of specific microorganisms in a sample using the amplification of DNA; provide an internal standard for the validation of the amplification of DNA |
| 01/01/2004 | US20040002073 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
| 01/01/2004 | US20040002072 Methods and apparatus for depositing biological materials in a pattern of array features on a surface of a solid support |
| 01/01/2004 | US20040002071 Genetic analysis for stratification of cancer risk |
| 01/01/2004 | US20040002069 A screening assay that identifies compounds which modulate the expression level of polynucleotides or functional properties of polypeptides that are over or under expressed in diabetes |
| 01/01/2004 | US20040002068 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/01/2004 | US20040002067 Based upon multiple sampling of reference breast tissue samples from independent cases of breast cancer and provide a reliable set of molecular criteria for identification of cells as being in one or more particular stages of breast cancer |
| 01/01/2004 | US20040002065 Protein/solubility folding assessed by structural complementation |
| 01/01/2004 | US20040002061 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells |
| 01/01/2004 | US20040002059 Screening method and a screening system capable of selecting agents capable of interfering with this protein-protein interaction; selection of agents capable of modulating this protein-protein interaction for treatment and control of PV |
| 01/01/2004 | US20040002056 Used in methods of screening for candidate bioactive agents that produce an altered phenotype in the cells |
| 01/01/2004 | US20040002055 Support with collage base for tissue engineering and manufacture of biomaterials |
| 01/01/2004 | US20040002054 Associated with connective tissue diseases, progeroid disorders, and aging; methods for isolating such molecules; and the use of such molecules in human and veterinary practice |
| 01/01/2004 | US20040001863 Immortal cell line derived from grouper Epinephelus coioides and its applications therein |
| 01/01/2004 | US20040001850 Dna sequences; genetic engineering |
| 01/01/2004 | US20040001846 Prostate-specific membrane antigen and uses thereof |
| 01/01/2004 | US20040001841 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/01/2004 | US20040001840 Cancer-linked gene as target for chemotherapy |
| 01/01/2004 | US20040001833 Method of treating cancer using kinase inhibitors |
| 01/01/2004 | US20040001832 Childhood obesity; antidiabetic agents; culture product; hybrid nucleic acid |
| 01/01/2004 | US20040001805 Prevention infections; gene therapy; insertion of genome; genetic engineered vaccine |
| 01/01/2004 | US20040001804 LLT uses thereof in immune system modulation |
| 01/01/2004 | US20040001803 Effectors of innate immunity determination |
| 01/01/2004 | US20040000901 Oocyte recording chamber |
| 12/31/2003 | WO2004001655A1 Methods of treating and preventing colitis involving il-13 and nk-t cells |
| 12/31/2003 | WO2004001506A2 Antireflective coatings for high-resolution photolithographic synthesis of dna array |
| 12/31/2003 | WO2004001424A1 Materials and methods for inductions of immune tolerance |
| 12/31/2003 | WO2004001420A2 Method and reagent for specifically identifying and quantifying one or more proteins in a sample |
| 12/31/2003 | WO2004001412A1 Dna microarray having standard probe and kit containing the array |
| 12/31/2003 | WO2004001410A1 Methods for identifying glucose uptake modulators |
| 12/31/2003 | WO2004001403A1 Method and device for high sensitivity detection of the presence of dna and other probes |
| 12/31/2003 | WO2004001379A2 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |